Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma.
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma.
复制标题
DOI:
10.1038/leu.2009.236
复制
发表时间:
2010-01
期刊:
影响因子:
11.4
通讯作者:
Prince, H. M.
中科院分区:
文献类型:
--
作者:
Quach, H.;Ritchie, D.;Stewart, A. K.;Neeson, P.;Harrison, S.;Smyth, M. J.;Prince, H. M.
Immunomodulatory drugs (IMiDs) are thalidomide analogues, which possess pleiotropic anti-myeloma properties including immune-modulation, anti-angiogenic, anti-inflammatory and anti-proliferative effects. Their development was facilitated by an improved understanding in myeloma (MM) biology and initiated a profound shift in the therapeutic approach towards MM. Despite the diverse effects of IMiDs in vitro, the relative contribution of each effect towards their ultimate anti-MM activity is still unclear. Based on in vitro data, it appears that anti-proliferative effects and downregulation of crucial cytokines are their most important anti-MM attributes. Although the co-stimulatory effects on T and NK cells have been heralded as a unique and important property of IMiDs towards enhancing anti-MM immune activity, these in vitro effects have yet to be firmly corroborated in vivo. Much is yet to be elucidated regarding the complex interplay of immunomodulatory cytokines that occurs in vivo, which ultimately dictates the net effects of IMiDs in MM—the understanding of which is necessary to facilitate optimal manipulation of these drugs in future MM management.
登录
查看更多内容
影响因子:
64.8
作者:
Bettelli, E;Carrier, YJ;Kuchroo, VK
通讯作者:
Kuchroo, VK
影响因子:
20.3
作者:
Carreras, Joaquim;Lopez-Guillermo, Armando;Banham, Alison H.
通讯作者:
Banham, Alison H.
影响因子:
5.7
作者:
Corral, LG;Muller, GW;Kaplan, G
通讯作者:
Kaplan, G
影响因子:
6.5
作者:
Feyler, Sylvia;von Lilienfeld-Toal, Marie;Cook, Gordon
通讯作者:
Cook, Gordon
影响因子:
3.1
作者:
Dredge, K;Horsfall, R;Bartlett, JB
通讯作者:
Bartlett, JB